Buscar resultados de ensayos clínicos
Chromophil Renal Cell Carcinoma - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma Condición: Papillary Renal Cell Carcinoma Fecha: 2015-06-19 Intervenciones: Drug: axitinib Other Name: Inlyta |
Recruiting |
Nombre del estudio: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Condición:
|
Recruiting |
Nombre del estudio: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer Condición: Papillary Renal Cell Carcinoma Fecha: 2013-12-20 Intervenciones: Drug: INC280 Supplied by Novartis as film-coated tablet for oral use. |
Completed |
Nombre del estudio: A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) Condición: Carcinoma, Renal Cell Fecha: 2008-07-29 Intervenciones: Drug: foretinib (formerly GSK1363089 or XL880) treatment with oral foretinib on one of 2 dosing regimens |
Active, not recruiting |
Nombre del estudio: A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) Condición: Papillary Renal Cell Cancer Fecha: 2014-04-23 Intervenciones: Drug: AZD6094 AZD6094 is a potent and selective small molecule cMet kinase inhibitor. |
Active, not recruiting |
Nombre del estudio: Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery Condición:
Intervenciones: |
Terminated |
Nombre del estudio: Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer Condición: Kidney Cancer Fecha: 2008-01-22 Intervenciones: Biological: bevacizumab 15 mg/kg over 90 minutes every 3 weeks |
Terminated |
Nombre del estudio: Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer Condición: Kidney Cancer Fecha: 2007-10-05 Intervenciones: Drug: sunitinib malate |
Completed |
Nombre del estudio: Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Condición: Kidney Cancer Fecha: 2007-04-11 Intervenciones: Drug: sunitinib malate |
Not yet recruiting |
Nombre del estudio: Savolitinib vs. Sunitinib in MET-driven PRCC Condición:
Intervenciones: |